The UNMC College of Medicine recently received grants and awards representing more than $3.8 million in new funding. The following individuals received awards:
- Joseph A. Fernandes, MD, neurological sciences, received a grant of $430,000 from Massachusetts General Hospital for the ALL ALS Consortium Project.
- Jeffrey Salomon, MD, pediatrics-critical care, received funding a grant of $350,000 from the Gerber Foundation for a study of the safety and tolerability of butyric acid and the effect on gut health and inflammation after pediatric cardiac surgery.
- Amy Cannella, MD, internal medicine-rheumatology, received a grant of $100,000 from the Rheumatology Research Foundation for an RRF training grant.
- Bryant England, MD, PhD, internal medicine-rheumatology, received grants of $61,807, $45,086, $7,869 and $5,020 from the Nebraska Educational Biomedical Research Association for ICAs for Jean Kwizerimana, Punyasha Roul, Alberto Esposito and Aimee Schreiner.
- James Ahodantin, PhD, pharmacology and experimental neuroscience, received a grant of $50,000 from the American Liver Foundation for a study of tolerogenic plasmacytoid dendritic cells in autoimmune hepatitis.
- Josue Avecillas Chasin, MD, PhD, neurosurgery, received a grant of $40,578 from Duke University for a study of intracranial neurophysiological signatures of fear and anxiety in humans.
- Ted Mikuls, MD, internal medicine-rheumatology, received a grant of $34,607 from the Nebraska Educational Biomedical Research Association for ICA for the Duryee-Mikuls project.
- Beth Hartman, MD, neurological sciences, received a grant of $32,396 from the Mayo Clinic for ICA for a comparative effectiveness study of oral medications used for migraine prevention.
- Scott Lundgren, DO, internal medicine-cardiovascular, received a grant of $29,500 from Houston Methodist Research Institute for M-CARE: MMDX-Clinical Assessment Registry.
- Arenn Carlos, MD, neurological sciences, received a grant of $5,000 from the American Academy of Neurology for a study of cerebrovascular reactivity as a screening and monitoring tool for amyloid-beta burden in Alzheimer’s disease patients receiving anti-amyloid immunotherapy.
- Jill Beck, MD, pediatrics-hematology/oncology, received funding a grant of $4,200 from Children’s Hospital of Philadelphia for a data-use agreement for “A Retrospective Study of Contemporary Approaches to First Relapse in B-ALL.”
Industry-sponsored grants and contracts:
The following industry-sponsored grants and contracts were received.
- Dr. Lundgren also received funding for investigation of a novel, magnetically levitated VAD for the treatment of refractory left ventricular heart failure.
- Scott Koepsell, MD, PhD, pathology, microbiology and immunology, received funding for multisite management study for collection of samples from subjects suspected of venous thromboembolism (VTE) for a D-dimer clinical study.
- Laura Tenner, MD, internal medicine-oncology/hematology, received funding to evaluate the safety and efficacy of MK-1084, Cetuximab and mFOLFOX6 vs. mFOLFOX6 with or without Bevacizumab.
- Ruxana Sadikot, MD, internal medicine-pulmonary, received funding to assess the efficacy, safety and tolerability of BI 1291583 2.5 mg administered once daily for up to 76 weeks in patients with bronchiectasis.
- Shubham Agarwhal, MD, internal medicine-DEM, received funding to study the effect of ZT-01 on frequency of nocturnal hypoglycemia in Type 1 diabetes mellitus.
- Carlos Gomez, MD, internal medicine-infectious diseases, received funding for a trial assessing the clinical utility of plasma-based microbial cell-free metagenomic sequencing among immunocompromised patients. Dr. Gomez also received funding for “Strategies and treatments for respiratory and viral emergencies protocol.”
- Anum Abbas, MD, internal medicine-infectious diseases, received funding for a study to evaluate the persistence of immune response of the adjuvanted RSVPreF3 vaccine and the safety and immunogenicity following revaccination in lung and kidney transplant.
- Gwen Skar, MD, pediatrics-infectious diseases, received funding for pediatric CSF biomarkers.